SEP 13, 2017 7:30 AM PDT

Keynote Presentation: Using phage to select for evolution of reduced virulence in pathogenic bacteria

Speaker
  • Henry Ford II Professor and Departmental Chair of Ecology and Evolutionary Biology, Microbiology Faculty, Yale School of Medicine
    Biography
      Paul Turner is the Elihu Professor of Ecology and Evolutionary Biology at Yale University, where he has served as Interim Dean of Science and Departmental Chair. He is also a faculty member in Microbiology at Yale University School of Medicine. Dr. Turner's research interests include: evolutionary biology, evolutionary medicine, infectious disease, microbiology, phage therapy, RNA viruses, vector-borne disease, and virology. He uses an interdisciplinary approach in his research laboratory, employing techniques from microbiology, population genetics, genomics, molecular biology and mathematical modeling to study hypotheses in ecology and evolutionary biology.

      Paul Turner received his Ph.D. from the Center for Microbial Ecology at Michigan State University. He then conducted postdoctoral work at University of Maryland College Park, University of Valencia in Spain, and the National Institutes of Health. He regularly serves on committees for the National Science Foundation, National Institutes of Health and the American Society for Microbiology. He was elected chair of international meetings, such as the 2013 Gordon Research Conference on Microbial Population Biology, and the 2018 Jacques Monod Conference on Viral Emergence. He has authored nearly 100 scholarly journal articles, reviews and book chapters.

    Abstract

    Increasing prevalence and severity of multi-drug-resistant (MDR) bacterial infections has necessitated novel antibacterial strategies.  Ideally, new approaches would target bacterial pathogens while exerting selection for reduced pathogenesis when these bacteria inevitably evolve resistance to therapeutic intervention. As an example of such a management strategy, we isolated a lytic bacteriophage, OMKO1, (family Myoviridae) of Pseudomonas aeruginosa that utilizes the outer membrane porin M (OprM) of the multidrug efflux systems MexAB and MexXY as a receptor-binding site. Results show that phage selection produces an evolutionary trade-off in MDR P. aeruginosa, whereby the evolution of bacterial resistance to phage attack changes the efflux pump mechanism, causing increased sensitivity to drugs from several antibiotic classes. Although modern phage therapy is still in its infancy, we conclude that phages, such as OMKO1, represent a new approach to phage therapy where bacteriophages exert selection for MDR bacteria to become increasingly sensitive to traditional antibiotics. This approach, using phages as targeted antibacterials, could extend the lifetime of our current antibiotics and potentially reduce the incidence of antibiotic resistant infections.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    SEP 13, 2017 7:30 AM PDT

    Keynote Presentation: Using phage to select for evolution of reduced virulence in pathogenic bacteria


    Specialty

    Pharmacology

    Microbiology

    Earth Sciences

    Research

    Personalized Medicine

    T-Cells

    Toxicology

    Immunology

    Manufacturing

    Biochemistry

    Ecology

    Health

    Research And Development

    Disease

    Staphylococcus (Staph Infection)

    Geography

    North America60%

    Asia20%

    Europe20%

    Registration Source

    Website Visitors100%

    Job Title

    Student25%

    QC/QA25%

    Research Scientist25%

    Medical Laboratory Technician25%

    Organization

    Research Institute40%

    Medical Center20%

    Manufacturer - Other20%

    Other20%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more